Brazil suspends phase-3 trials of Covaxin

After Bharat Biotech terminated its MoU with Brazilian partner Precisa Medicamentos on Friday, Brazil’s health regulator Anvisa (Agencia Nacional de Vigilancia Sanitaria) said it has suspended Covaxin’s clinical trials in Brazil. Precisa had submitted a request for randomised, double-blind and placebo-controlled phase-3 study of Covaxin in Brazil to Anvisa.

from Hyderabad News: Latest Hyderabad News Headlines & Live News Updates from Hyderabad - Times of India https://ift.tt/3x2GM08